Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004582523 | SCV005067884 | pathogenic | GM3 synthase deficiency | 2023-08-22 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with ST3GAL5-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 4-5 of the ST3GAL5 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. This variant disrupts a region of the ST3GAL5 protein in which other variant(s) (p.Gly201Arg) have been determined to be pathogenic (PMID: 27232954). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |